VAUGHAN, Ontario—Bausch + Lomb Corporation (NYSE/TSX: BLCO), a global eye health company and contact lens maker, announced that it has ended negotiations for a potential sale with a third-party buyer. In December of 2024, as reported in VMAIL, the company said it was exploring a potential sale and other options that would lead to a full separation from parent company Bausch Health Companies Inc. Last week, Bausch + Lomb issued the following update on a potential sale, which was disclosed in December following a request from the Canadian Investment Regulatory Organization. Read More